Femke Mathot

3 MSC-seeding on processed nerve allografts 57 myelination and enhance functional recovery in a rat model of chronic denervation. J Neurosci Res 2012: 90: 1392-402. 24. Kingham PJ, Kolar MK, Novikova LN, Novikov LN, Wiberg M. Stimulating the neurotrophic and angiogenic properties of human adipose-derived stem cells enhances nerve repair. Stem Cells Dev 2014: 23: 741-54. 25. Tomita K, Madura T, Sakai Y, et al. Glial differentiation of human adipose-derived stem cells: implications for cell-based transplantation therapy. Neuroscience 2013: 236: 55-65. 26. Liu Y, Zhang Z, Qin Y, et al. A new method for Schwann-like cell differentiation of adipose derived stem cells. Neurosci Lett 2013: 551: 79-83. 27. Jesuraj NJ, Santosa KB, Newton P, et al. A systematic evaluation of Schwann cell injection into acellular cold-preserved nerve grafts. J Neurosci Methods 2011: 197: 209-15. 28. Thompson MJ, Patel G, Isaacs J, et al. Introduction of neurosupportive cells into processed acellular nerve allografts results in greater number and more even distribution when injected compared to soaking techniques. Neurol Res 2017: 39: 189-97. 29. Rbia N, Bulstra LF, Bishop AT, van Wijnen AJ, Shin AY. A simple dynamic strategy to deliver stem cells to decellularized nerve allografts. Plast Reconstr Surg 2018. 30. Hundepool CA, Nijhuis TH, Kotsougiani D, et al. Optimizing decellularization techniques to create a new nerve allograft: an in vitro study using rodent nerve segments. Neurosurg Focus 2017: 42. 31. Hudson TW, Zawko S, Deister C, et al. Optimized acellular nerve graft is immunologically tolerated and supports regeneration. Tissue Eng 2004: 10: 1641-51. 32. Kumta S, Yip K, Roy N, Lee SK, Leung PC. Revascularisation of bone allografts following vascular bundle implantation: an experimental study in rats. Arch Orthop Trauma Surg 1996: 115: 206-10. 33. Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991: 3: 207-12. 34. Volarevic V, Markovic BS, Gazdic M, et al. Ethical and Safety Issues of Stem Cell-Based Therapy. Int J Med Sci 2018: 15: 36-45. 35. Lazennec G, Jorgensen C. Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 2008: 26: 1387-94. 36. Orbay H, Uysal AC, Hyakusoku H, Mizuno H. Differentiated and undifferentiated adipose-derived stem cells improve function in rats with peripheral nerve gaps. J Plast Reconstr Aesthet Surg 2012: 65: 657-64. 37. Watanabe Y, Sasaki R, Matsumine H, Yamato M, Okano T. Undifferentiated and differentiated adipose-derived stem cells improve nerve regeneration in a rat model of facial nerve defect. J Tissue Eng Regen Med 2017: 11: 362-74. 38. Garvican ER, Cree S, Bull L, Smith RK, Dudhia J. Viability of equine mesenchymal stem cells during transport and implantation. Stem Cell Res Ther 2014: 5: 94. 39. Agashi K, Chau DY, Shakesheff KM. The effect of delivery via narrow-bore needles on mesenchymal cells. Regen Med 2009: 4: 49-64. 40. Mamidi MK, Singh G, Husin JM, et al. Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications. J Transl Med 2012: 10: 229. 41. Sunderland S, Lavarack JO, Ray LJ. The caliber of nerve fibers in human cutaneous nerves. J COMP NEUROL 1949: 91: 87-101. 42. Ryu YJ, Cho TJ, Lee DS, Choi JY, Cho J. Phenotypic characterization and in vivo localization of human adipose-derived mesenchymal stem cells. Mol Cells 2013: 35: 557-64. 43. Ge J, Guo L, Wang S, et al. The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev 2014: 10: 295-303. 44. Caplan AI, Hariri R. Body Management: Mesenchymal Stem Cells Control the Internal Regenerator. Stem Cells Transl Med 2015: 4: 695-701.